Interstitial Lung Disease Trial, Recruiting (NCT06615492)

Interstitial Lung Disease Trial, Recruiting NCT06615492 Sponsor: Centre hospitalier de l'Université de Montréal (CHUM) Condition: Interstitial Lung Disease

Printed from Voxsanity (voxsanity.com.au) — NCT06615492 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Interstitial Lung Disease

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are scheduled to have a lung transplant surgery

Who may not be able to join:

You are not able to give your own consent to take part in the study
You are having a second lung transplant (a re-transplant)
You are receiving more than one organ at the same time (for example, a heart and lung transplant together)
You have a medical reason why you cannot receive the blood-thinning medication heparin — for example, if you have had a serious reaction to heparin in the past that caused your platelet count to drop (confirm with trial site)
You have severely high blood pressure in the arteries of your lungs, based on recent test results from an ultrasound of the heart, a heart catheter procedure, or a pressure monitor in the lung artery (confirm with trial site)
The right side of your heart is not pumping properly or is significantly weakened
The left side of your heart is not pumping well enough — specifically, if it is pumping out less than 45% of blood with each beat, based on a heart scan or imaging test
You need heart surgery at the same time as your lung transplant — for example, surgery to treat blocked heart arteries

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 22 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 514-890-8000

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06615492

Sponsor: Centre hospitalier de l'Université de Montréal (CHUM)

Phase: Not Applicable

Status: Recruiting

Condition: Interstitial Lung Disease

Trial contact: 514-890-8000

More information: https://clinicaltrials.gov/study/NCT06615492

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are scheduled to have a lung transplant surgery

Who may not be able to join:

You are not able to give your own consent to take part in the study
You are having a second lung transplant (a re-transplant)
You are receiving more than one organ at the same time (for example, a heart and lung transplant together)
You have a medical reason why you cannot receive the blood-thinning medication heparin — for example, if you have had a serious reaction to heparin in the past that caused your platelet count to drop (confirm with trial site)
You have severely high blood pressure in the arteries of your lungs, based on recent test results from an ultrasound of the heart, a heart catheter procedure, or a pressure monitor in the lung artery (confirm with trial site)
The right side of your heart is not pumping properly or is significantly weakened
The left side of your heart is not pumping well enough — specifically, if it is pumping out less than 45% of blood with each beat, based on a heart scan or imaging test
You need heart surgery at the same time as your lung transplant — for example, surgery to treat blocked heart arteries

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 22 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Centre hospitalier de l'Université de Montréal (CHUM)

Registry

ClinicalTrials.gov

Start date

5 November 2024

Est. completion

5 November 2028

Where this trial is recruiting

🇨🇦 Canada

Primary endpoints

ICU-free days

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov